Meglu Tablet 500 mg contains Metformin Hydrochloride, a widely prescribed oral antihyperglycemic agent used in the management of type 2 diabetes mellitus. Metformin belongs to the biguanide class of medications and helps control blood glucose levels through multiple mechanisms, without stimulating insulin secretion.

Metformin primarily works by reducing hepatic glucose production (gluconeogenesis) and improving insulin sensitivity in peripheral tissues such as muscle and fat. Additionally, it enhances glucose uptake and utilization, helping to lower fasting and postprandial blood sugar levels. Meglu Tablet 500 mg is also associated with weight neutrality or modest weight loss, making it suitable for overweight or obese patients with type 2 diabetes.

This formulation is intended for oral administration, offering convenient dosing to help patients maintain long-term glycemic control.

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Indications

Meglu Tablet 500 mg is indicated for:

• Type 2 diabetes mellitus in adults and adolescents (10 years and older), particularly in patients with overweight or obesity

• Monotherapy in patients not adequately controlled by diet and exercise alone

• Combination therapy with other antidiabetic agents (oral or injectable), including insulin, when monotherapy is insufficient

• Prevention of type 2 diabetes in high-risk individuals, under medical supervision

Meglu helps to maintain optimal blood glucose levels, reduce the risk of diabetes-related complications, and improve overall metabolic health.

Dosage and Administration

Recommended dosage:

• Adults: Typically 500 mg once or twice daily, with dose adjustments based on blood glucose response

• Maximum daily dose: 2,000–2,500 mg, divided into 2–3 doses depending on clinical guidance

• Pediatric patients: Dose is determined based on weight and physician recommendation

Administration guidelines:

• Take with meals to reduce gastrointestinal discomfort

• Swallow tablets whole; do not crush or chew extended-release forms

• Maintain a consistent daily schedule for optimal glycemic control

• Regular blood glucose monitoring is advised to evaluate effectiveness

Precautions and Warnings

• Lactic acidosis risk: Rare but serious; more likely in patients with renal impairment, liver disease, severe infection, or dehydration

• Renal function monitoring: Metformin is contraindicated in patients with severe renal impairment

• Hepatic impairment: Use cautiously in patients with liver disease

• Contrast studies: Temporary discontinuation may be necessary before iodinated contrast imaging to prevent renal complications

• Pregnancy and breastfeeding: Generally considered safe under medical supervision, but consult a physician before use

• Alcohol: Excessive alcohol intake may increase the risk of lactic acidosis

  রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Possible Side Effects

Meglu Tablet 500 mg is generally well tolerated. Common side effects include:

• Gastrointestinal discomfort: nausea, vomiting, diarrhea, bloating, and abdominal pain

• Mild metallic taste

• Rare: vitamin B12 deficiency with long-term use

Most side effects are transient and diminish with continued therapy or dose adjustment. Severe adverse reactions, such as lactic acidosis, are extremely rare but require immediate medical attention.

Storage

Store in a cool, dry place below 25°C, protected from light and moisture. Keep tablets in their original container and out of reach of children.

Meglu Tablet 500 mg (Metformin Hydrochloride) is an effective, first-line oral antidiabetic agent that provides glycemic control, metabolic benefits, and long-term cardiovascular protection, making it a cornerstone in the management of type 2 diabetes.